{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:56:13Z","timestamp":1770890173273,"version":"3.50.1"},"reference-count":295,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/MED-NEU\/1240\/2021"],"award-info":[{"award-number":["EXPL\/MED-NEU\/1240\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"La Fondation J\u00e9r\u00f4me Lejeune","award":["2379-GRT-2024A"],"award-info":[{"award-number":["2379-GRT-2024A"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Redox Report"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13510002.2025.2592413","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:56:36Z","timestamp":1765817796000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer\u2019s and Parkinson\u2019s diseases"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-0633","authenticated-orcid":false,"given":"S\u00f3nia","family":"Sim\u00e3o","sequence":"first","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]},{"name":"Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]},{"name":"ABC Collaborative Laboratory \u2013 Integrated Ageing and Rejuvenation Solutions (ABC CoLAB), University of Algarve","place":["Faro, Portugal"]}]},{"given":"Daniela F.","family":"Santos","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]}]},{"given":"Mariana","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]},{"name":"Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]},{"name":"ABC Collaborative Laboratory \u2013 Integrated Ageing and Rejuvenation Solutions (ABC CoLAB), University of Algarve","place":["Faro, Portugal"]},{"name":"PhD Program in Biomedical Sciences, Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]}]},{"given":"Rafaela R.","family":"Agostinho","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]},{"name":"Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]},{"name":"PhD Program in Biomedical Sciences, Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]}]},{"given":"Joana","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]},{"name":"Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]},{"name":"ABC Collaborative Laboratory \u2013 Integrated Ageing and Rejuvenation Solutions (ABC CoLAB), University of Algarve","place":["Faro, Portugal"]},{"name":"PhD Program in Biomedical Sciences, Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]}]},{"given":"Marta","family":"Vitorino","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]},{"name":"Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2438-0111","authenticated-orcid":false,"given":"In\u00eas M.","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center Research Institute (ABC\u2013Ri), University of Algarve","place":["Faro, Portugal"]},{"name":"Algarve Biomedical Center (ABC), University of Algarve","place":["Faro, Portugal"]},{"name":"Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve","place":["Faro, Portugal"]},{"name":"ABC Collaborative Laboratory \u2013 Integrated Ageing and Rejuvenation Solutions (ABC CoLAB), University of Algarve","place":["Faro, Portugal"]}]}],"member":"301","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","unstructured":"Kriegstein A Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009;32:149\u2013184. doi:10.1146\/annurev.neuro.051508.135600","DOI":"10.1146\/annurev.neuro.051508.135600"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"Ming GL Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron. 2011;70:687\u2013702. doi:10.1016\/j.neuron.2011.05.001","DOI":"10.1016\/j.neuron.2011.05.001"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","unstructured":"Kempermann G Song H Gage FH. Neurogenesis in the adult hippocampus. Cold Spring Harb Perspect Biol. 2015;7:a018812. doi:10.1101\/cshperspect.a018812","DOI":"10.1101\/cshperspect.a018812"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Vaz A Ribeiro I Pinto L. Frontiers in neurogenesis. Cells. 2022;11; doi:10.3390\/cells11223567","DOI":"10.3390\/cells11223567"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"Altman J Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965;124:319\u2013335. doi:10.1002\/cne.901240303","DOI":"10.1002\/cne.901240303"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","unstructured":"Altman J. Are new neurons formed in the brains of adult mammals? Science. 1962;135:1127\u20131128. doi:10.1126\/science.135.3509.1127","DOI":"10.1126\/science.135.3509.1127"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Eriksson PS Perfilieva E Bjork-Eriksson T et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313\u20131317. doi:10.1038\/3305","DOI":"10.1038\/3305"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","unstructured":"Boldrini M Fulmore CA Tartt AN et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22:589\u2013599 e585. doi:10.1016\/j.stem.2018.03.015","DOI":"10.1016\/j.stem.2018.03.015"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Moreno-Jimenez EP Flor-Garcia M Terreros-Roncal J et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease. Nat Med. 2019;25:554\u2013560. doi:10.1038\/s41591-019-0375-9","DOI":"10.1038\/s41591-019-0375-9"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","unstructured":"Tobin MK Musaraca K Disouky A et al. Human hippocampal neurogenesis persists in aged adults and Alzheimer's disease patients. Cell Stem Cell. 2019;24:974\u2013982 e973. doi:10.1016\/j.stem.2019.05.003","DOI":"10.1016\/j.stem.2019.05.003"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","unstructured":"Sorrells SF Paredes MF Cebrian-Silla A et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555:377\u2013381. doi:10.1038\/nature25975","DOI":"10.1038\/nature25975"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Dennis CV Suh LS Rodriguez ML et al. Human adult neurogenesis across the ages: An immunohistochemical study. Neuropathol Appl Neurobiol. 2016;42:621\u2013638. doi:10.1111\/nan.12337","DOI":"10.1111\/nan.12337"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Doetsch F Caille I Lim DA et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703\u2013716. doi:10.1016\/s0092-8674(00)80783-7","DOI":"10.1016\/S0092-8674(00)80783-7"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Doetsch F Scharff C. Challenges for brain repair: insights from adult neurogenesis in birds and mammals. Brain Behav Evol. 2001;58:306\u2013322. doi:10.1159\/000057572","DOI":"10.1159\/000057572"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","unstructured":"Curtis MA Kam M Nannmark U et al. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science. 2007;315:1243\u20131249. doi:10.1126\/science.1136281","DOI":"10.1126\/science.1136281"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","unstructured":"Lois C Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science. 1994;264:1145\u20131148. doi:10.1126\/science.8178174","DOI":"10.1126\/science.8178174"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Carleton A Petreanu LT Lansford R et al. Becoming a new neuron in the adult olfactory bulb. Nat Neurosci. 2003;6:507\u2013518. doi:10.1038\/nn1048","DOI":"10.1038\/nn1048"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Kempermann G Kuhn HG Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature. 1997;386:493\u2013495. doi:10.1038\/386493a0","DOI":"10.1038\/386493a0"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","unstructured":"Kuhn HG Dickinson-Anson H Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci. 1996;16:2027\u20132033. doi:10.1523\/JNEUROSCI.16-06-02027.1996","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","unstructured":"Gould E Reeves AJ Graziano MS et al. Neurogenesis in the neocortex of adult primates. Science. 1999;286:548\u2013552. doi:10.1126\/science.286.5439.548","DOI":"10.1126\/science.286.5439.548"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","unstructured":"Inta D Cameron HA Gass P. New neurons in the adult striatum: from rodents to humans. Trends Neurosci. 2015;38:517\u2013523. doi:10.1016\/j.tins.2015.07.005","DOI":"10.1016\/j.tins.2015.07.005"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","unstructured":"Bernier PJ Bedard A Vinet J et al. Newly generated neurons in the amygdala and adjoining cortex of adult primates. Proc Natl Acad Sci U S A. 2002;99:11464\u201311469. doi:10.1073\/pnas.172403999","DOI":"10.1073\/pnas.172403999"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Zhao M Momma S Delfani K et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A. 2003;100:7925\u20137930. doi:10.1073\/pnas.1131955100","DOI":"10.1073\/pnas.1131955100"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","unstructured":"Leal-Galicia P Chavez-Hernandez ME Mata F et al. Adult neurogenesis: A story ranging from controversial new neurogenic areas and human adult neurogenesis to molecular regulation. Int J Mol Sci. 2021;22; doi:10.3390\/ijms222111489","DOI":"10.3390\/ijms222111489"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","unstructured":"Jurkowski MP Bettio L et al KWE. Beyond the hippocampus and the SVZ: adult neurogenesis throughout the brain. Front Cell Neurosci. 2020;14:576444. doi:10.3389\/fncel.2020.576444","DOI":"10.3389\/fncel.2020.576444"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","unstructured":"Shohayeb B Diab M Ahmed M et al. Factors that influence adult neurogenesis as potential therapy. Transl Neurodegener. 2018;7:4. doi:10.1186\/s40035-018-0109-9","DOI":"10.1186\/s40035-018-0109-9"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","unstructured":"Zhang X Wei X Mei Y et al. Modulating adult neurogenesis affects synaptic plasticity and cognitive functions in mouse models of Alzheimer's disease. Stem Cell Reports. 2021;16:3005\u20133019. doi:10.1016\/j.stemcr.2021.11.003","DOI":"10.1016\/j.stemcr.2021.11.003"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","unstructured":"Fan Y Goh ELK Chan JKY. Neural cells for neurodegenerative diseases in clinical trials. Stem Cells Transl Med 2023;12:510\u2013526. doi:10.1093\/stcltm\/szad041","DOI":"10.1093\/stcltm\/szad041"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","unstructured":"Nie L Yao D Chen S et al. Directional induction of neural stem cells a new therapy for neurodegenerative diseases and ischemic stroke. Cell Death Discov. 2023;9:215. doi:10.1038\/s41420-023-01532-9","DOI":"10.1038\/s41420-023-01532-9"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","unstructured":"Oz T Kaushik A Kujawska M. Neural stem cells for Parkinson's disease management: challenges nanobased support and prospects. World J Stem Cells. 2023;15:687\u2013700. doi:10.4252\/wjsc.v15.i7.687","DOI":"10.4252\/wjsc.v15.i7.687"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","unstructured":"Shah AJ Dar MY Jan B et al. Neural stem cell therapy for Alzheimer\u2019s disease: a-state-of-the-art review. Journal of Dementia and Alzheimer\u2019s Disease. 2024;1:109\u2013125. doi:10.3390\/jdad1020008","DOI":"10.3390\/jdad1020008"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","unstructured":"Pourabdolhossein F Dehghan S Baron-Van Evercooren A et al. Editorial: activation and stimulation of endogenous neural stem\/progenitor cells in multiple sclerosis and other neurodegenerative diseases. Front Cell Neurosci. 2023;17:1305767. doi:10.3389\/fncel.2023.1305767","DOI":"10.3389\/fncel.2023.1305767"},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","unstructured":"Seo Y Han S Song BW et al. Endogenous neural stem cell activation after low-intensity focused ultrasound-induced blood-brain barrier modulation. Int J Mol Sci. 2023;24. doi:10.3390\/ijms24065712","DOI":"10.3390\/ijms24065712"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","unstructured":"Leinenga G Gotz J. Scanning ultrasound removes amyloid-beta and restores memory in an Alzheimer's disease mouse model. Sci Transl Med. 2015;7:278ra233. doi:10.1126\/scitranslmed.aaa2512","DOI":"10.1126\/scitranslmed.aaa2512"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","unstructured":"Chen T Lau KSK Singh A et al. Biodegradable stimulating electrodes for resident neural stem cell activation in vivo. Biomaterials. 2025;315:122957. doi:10.1016\/j.biomaterials.2024.122957","DOI":"10.1016\/j.biomaterials.2024.122957"},{"key":"e_1_3_2_37_1","doi-asserted-by":"crossref","unstructured":"Wang R. Gasotransmitters: growing pains and joys. Biochem Sci. 2014;39:227\u2013232. doi:10.1016\/j.tibs.2014.03.003","DOI":"10.1016\/j.tibs.2014.03.003"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","unstructured":"Wang R. Two's company three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 2002;16:1792\u20131798. doi:10.1096\/fj.02-0211hyp","DOI":"10.1096\/fj.02-0211hyp"},{"key":"e_1_3_2_39_1","doi-asserted-by":"crossref","unstructured":"Jiang S Chen H Shen P et al. Gasotransmitter research advances in respiratory diseases. Antioxid Redox Signal. 2024;40:168\u2013185. doi:10.1089\/ars.2023.0410","DOI":"10.1089\/ars.2023.0410"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","unstructured":"Ignarro LJ Buga GM Wood KS et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265\u20139269. doi:10.1073\/pnas.84.24.9265","DOI":"10.1073\/pnas.84.24.9265"},{"key":"e_1_3_2_41_1","doi-asserted-by":"crossref","unstructured":"Furchgott RF. The 1996 Albert Lasker medical research awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA. 1996;276:1186\u20131188.","DOI":"10.1001\/jama.1996.03540140074032"},{"key":"e_1_3_2_42_1","doi-asserted-by":"crossref","unstructured":"Palmer RM Ashton DS Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664\u2013666. doi:10.1038\/333664a0","DOI":"10.1038\/333664a0"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","unstructured":"Bredt DS Hwang PM Glatt CE et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714\u2013718. doi:10.1038\/351714a0","DOI":"10.1038\/351714a0"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","unstructured":"Andrabi SM Sharma NS Karan A et al. Nitric oxide: physiological functions delivery and biomedical applications. Adv Sci (Weinh). 2023;10:e2303259. doi:10.1002\/advs.202303259","DOI":"10.1002\/advs.202303259"},{"key":"e_1_3_2_45_1","doi-asserted-by":"crossref","unstructured":"Moncada S Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002\u20132012. doi:10.1056\/NEJM199312303292706","DOI":"10.1056\/NEJM199312303292706"},{"key":"e_1_3_2_46_1","doi-asserted-by":"crossref","unstructured":"Panda K Rosenfeld RJ Ghosh S et al. Distinct dimer interaction and regulation in nitric-oxide synthase types I II and III. J Biol Chem. 2002;277:31020\u201331030. doi:10.1074\/jbc.M203749200","DOI":"10.1074\/jbc.M203749200"},{"key":"e_1_3_2_47_1","doi-asserted-by":"crossref","unstructured":"Nagase S Ueda A Hirayama A et al. NO is not exclusively generated by the reaction of L-arginine and NOS and is poorly identified by the Griess reaction or clark-type electrodes. Nephron. 1997;77:489. doi:10.1159\/000190334","DOI":"10.1159\/000190334"},{"key":"e_1_3_2_48_1","doi-asserted-by":"crossref","unstructured":"Zhang Z Naughton D Winyard PG et al. Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun. 1998;249:767\u2013772. doi:10.1006\/bbrc.1998.9226","DOI":"10.1006\/bbrc.1998.9226"},{"key":"e_1_3_2_49_1","doi-asserted-by":"crossref","unstructured":"Jansson EA Huang L Malkey R et al. A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol. 2008;4:411\u2013417. doi:10.1038\/nchembio.92","DOI":"10.1038\/nchembio.92"},{"key":"e_1_3_2_50_1","doi-asserted-by":"crossref","unstructured":"Kozlov AV Staniek K Nohl H. Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett. 1999;454:127\u2013130. doi:10.1016\/s0014-5793(99)00788-7","DOI":"10.1016\/S0014-5793(99)00788-7"},{"key":"e_1_3_2_51_1","doi-asserted-by":"crossref","unstructured":"Forstermann U Closs EI Pollock JS et al. Nitric oxide synthase isozymes. Characterization purification molecular cloning and functions. Hypertension. 1994;23:1121\u20131131. doi:10.1161\/01.hyp.23.6.1121","DOI":"10.1161\/01.HYP.23.6.1121"},{"key":"e_1_3_2_52_1","doi-asserted-by":"crossref","unstructured":"Forstermann U Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829\u2013837 837a\u2013837d. doi:10.1093\/eurheartj\/ehr304","DOI":"10.1093\/eurheartj\/ehr304"},{"key":"e_1_3_2_53_1","doi-asserted-by":"crossref","unstructured":"Tricoire L Vitalis T. Neuronal nitric oxide synthase expressing neurons: a journey from birth to neuronal circuits. Front Neural Circuits. 2012;6:82. doi:10.3389\/fncir.2012.00082","DOI":"10.3389\/fncir.2012.00082"},{"key":"e_1_3_2_54_1","doi-asserted-by":"crossref","unstructured":"Guix FX Uribesalgo I Coma M et al. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005;76:126\u2013152. doi:10.1016\/j.pneurobio.2005.06.001","DOI":"10.1016\/j.pneurobio.2005.06.001"},{"key":"e_1_3_2_55_1","doi-asserted-by":"crossref","unstructured":"Marsden PA Schappert KT Chen HS et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992;307:287\u2013293. doi:10.1016\/0014-5793(92)80697-f","DOI":"10.1016\/0014-5793(92)80697-F"},{"key":"e_1_3_2_56_1","doi-asserted-by":"crossref","unstructured":"Forstermann U Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol. 2011;164:213\u2013223. doi:10.1111\/j.1476-5381.2010.01196.x","DOI":"10.1111\/j.1476-5381.2010.01196.x"},{"key":"e_1_3_2_57_1","doi-asserted-by":"crossref","unstructured":"Brenman JE Christopherson KS Craven SE et al. Cloning and characterization of postsynaptic density 93 a nitric oxide synthase interacting protein. J Neurosci. 1996;16:7407\u20137415. doi:10.1523\/JNEUROSCI.16-23-07407.1996","DOI":"10.1523\/JNEUROSCI.16-23-07407.1996"},{"key":"e_1_3_2_58_1","doi-asserted-by":"crossref","unstructured":"Farah C Michel LYM Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. 2018;15:292\u2013316. doi:10.1038\/nrcardio.2017.224","DOI":"10.1038\/nrcardio.2017.224"},{"key":"e_1_3_2_59_1","doi-asserted-by":"crossref","unstructured":"MacMicking J Xie QW Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323\u2013350. doi:10.1146\/annurev.immunol.15.1.323","DOI":"10.1146\/annurev.immunol.15.1.323"},{"key":"e_1_3_2_60_1","doi-asserted-by":"crossref","unstructured":"Azargoonjahromi A. Dual role of nitric oxide in Alzheimer's disease. Nitric Oxide. 2023;134-135:23\u201337. doi:10.1016\/j.niox.2023.03.003.","DOI":"10.1016\/j.niox.2023.03.003"},{"key":"e_1_3_2_61_1","doi-asserted-by":"crossref","unstructured":"Martinez-Ruiz A Cadenas S Lamas S. Nitric oxide signaling: classical less classical and nonclassical mechanisms. Free Radic Biol Med. 2011;51:17\u201329. doi:10.1016\/j.freeradbiomed.2011.04.010","DOI":"10.1016\/j.freeradbiomed.2011.04.010"},{"key":"e_1_3_2_62_1","doi-asserted-by":"crossref","unstructured":"Martinez-Ruiz A Lamas S. Two decades of new concepts in nitric oxide signaling: from the discovery of a gas messenger to the mediation of nonenzymatic posttranslational modifications. IUBMB Life. 2009;61:91\u201398. doi:10.1002\/iub.144","DOI":"10.1002\/iub.144"},{"key":"e_1_3_2_63_1","doi-asserted-by":"crossref","unstructured":"Picon-Pages P Garcia-Buendia J Munoz FJ. Functions and dysfunctions of nitric oxide in brain. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1949\u20131967. doi:10.1016\/j.bbadis.2018.11.007","DOI":"10.1016\/j.bbadis.2018.11.007"},{"key":"e_1_3_2_64_1","doi-asserted-by":"crossref","unstructured":"Garthwaite J. From synaptically localized to volume transmission by nitric oxide. J Physiol. 2016;594:9\u201318. doi:10.1113\/JP270297","DOI":"10.1113\/JP270297"},{"key":"e_1_3_2_65_1","volume-title":"Les gaz du sang: applications \u00e0 l'hygi\u00e8ne exp\u00e9rimentale","author":"Gr\u00e9hant N.","year":"1894","unstructured":"Gr\u00e9hant N. Les gaz du sang: applications \u00e0 l'hygi\u00e8ne exp\u00e9rimentale. G. Masson; 1894."},{"key":"e_1_3_2_66_1","doi-asserted-by":"crossref","unstructured":"Sjostrand T. Endogenous formation of carbon monoxide in man. Nature. 1949;164:580. doi:10.1038\/164580a0","DOI":"10.1038\/164580a0"},{"key":"e_1_3_2_67_1","doi-asserted-by":"crossref","unstructured":"Tenhunen R Marver HS Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61:748\u2013755. doi:10.1073\/pnas.61.2.748","DOI":"10.1073\/pnas.61.2.748"},{"key":"e_1_3_2_68_1","doi-asserted-by":"crossref","unstructured":"Tenhunen R Marver HS Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem. 1969;244:6388\u20136394.","DOI":"10.1016\/S0021-9258(18)63477-5"},{"key":"e_1_3_2_69_1","doi-asserted-by":"crossref","unstructured":"Verma A Hirsch DJ Glatt CE et al. Carbon monoxide: a putative neural messenger. Science. 1993;259:381\u2013384. doi:10.1126\/science.7678352","DOI":"10.1126\/science.7678352"},{"key":"e_1_3_2_70_1","doi-asserted-by":"crossref","unstructured":"Snyder SH Baranano DE. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology. 2001;25:294\u2013298. doi:10.1016\/S0893-133X(01)00275-5","DOI":"10.1016\/S0893-133X(01)00275-5"},{"key":"e_1_3_2_71_1","doi-asserted-by":"crossref","unstructured":"Huang Y Wu L Xu C et al. Increased HO-1 expression and decreased iNOS expression in the hippocampus from adult spontaneously hypertensive rats. Cell Biochem Biophys. 2006;46:35\u201342. doi:10.1385\/CBB:46:1:35","DOI":"10.1385\/CBB:46:1:35"},{"key":"e_1_3_2_72_1","doi-asserted-by":"crossref","unstructured":"Scapagnini G Foresti R Calabrese V et al. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol. 2002;61:554\u2013561. doi:10.1124\/mol.61.3.554","DOI":"10.1124\/mol.61.3.554"},{"key":"e_1_3_2_73_1","doi-asserted-by":"crossref","unstructured":"McCoubrey WK Jr. Huang TJ Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 1997;247:725\u2013732. doi:10.1111\/j.1432-1033.1997.00725.x","DOI":"10.1111\/j.1432-1033.1997.00725.x"},{"key":"e_1_3_2_74_1","doi-asserted-by":"crossref","unstructured":"Hayashi S Omata Y Sakamoto H et al. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene. 2004;336:241\u2013250. doi:10.1016\/j.gene.2004.04.002","DOI":"10.1016\/j.gene.2004.04.002"},{"key":"e_1_3_2_75_1","doi-asserted-by":"crossref","unstructured":"Wolff DG. The formation of carbon monoxide during peroxidation of microsomal lipids. Biochem Biophys Res Commun. 1976;73:850\u2013857. doi:10.1016\/0006-291x(76)90199-6","DOI":"10.1016\/0006-291X(76)90199-6"},{"key":"e_1_3_2_76_1","doi-asserted-by":"crossref","unstructured":"Archakov AI Karuzina II Petushkova NA et al. Production of carbon monoxide by cytochrome P450 during iron-dependent lipid peroxidation. Toxicol In Vitro. 2002;16:1\u201310. doi:10.1016\/s0887-2333(01)00094-7","DOI":"10.1016\/S0887-2333(01)00094-7"},{"key":"e_1_3_2_77_1","doi-asserted-by":"crossref","unstructured":"Sobieraj K Zebrowska-Rozanska P Siedlecka A et al. Analysis of microbial community potentially involved in carbon monoxide production in compost and its functional assessment: utilized pathways enzymes and genes. Sci Total Environ. 2025;968:178860. doi:10.1016\/j.scitotenv.2025.178860","DOI":"10.1016\/j.scitotenv.2025.178860"},{"key":"e_1_3_2_78_1","doi-asserted-by":"crossref","unstructured":"Wu L Wang R. Carbon monoxide: endogenous production physiological functions and pharmacological applications. Pharmacol Rev. 2005;57:585\u2013630. doi:10.1124\/pr.57.4.3","DOI":"10.1124\/pr.57.4.3"},{"key":"e_1_3_2_79_1","doi-asserted-by":"crossref","unstructured":"Kim HP Ryter SW Choi AM. CO as a cellular signaling molecule. Toxicol. 2006;46:411\u2013449. doi:10.1146\/annurev.pharmtox.46.120604.141053","DOI":"10.1146\/annurev.pharmtox.46.120604.141053"},{"key":"e_1_3_2_80_1","doi-asserted-by":"crossref","unstructured":"Wilkinson WJ Kemp PJ. Carbon monoxide: an emerging regulator of ion channels. J Physiol. 2011;589:3055\u20133062. doi:10.1113\/jphysiol.2011.206706","DOI":"10.1113\/jphysiol.2011.206706"},{"key":"e_1_3_2_81_1","doi-asserted-by":"crossref","unstructured":"Kanu A Gilpin D Fedinec AL et al. Cyclooxygenase products stimulate carbon monoxide production by piglet cerebral microvessels. Exp Biol Med (Maywood). 2006;231:181\u2013185. doi:10.1177\/153537020623100208","DOI":"10.1177\/153537020623100208"},{"key":"e_1_3_2_82_1","doi-asserted-by":"crossref","unstructured":"Poss KD Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A. 1997;94:10919\u201310924. doi:10.1073\/pnas.94.20.10919","DOI":"10.1073\/pnas.94.20.10919"},{"key":"e_1_3_2_83_1","doi-asserted-by":"crossref","unstructured":"Stocker R Yamamoto Y McDonagh AF et al. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043\u20131046. doi:10.1126\/science.3029864","DOI":"10.1126\/science.3029864"},{"key":"e_1_3_2_84_1","doi-asserted-by":"crossref","unstructured":"Kensler TW Wakabayashi N Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89\u2013116. doi:10.1146\/annurev.pharmtox.46.120604.141046","DOI":"10.1146\/annurev.pharmtox.46.120604.141046"},{"key":"e_1_3_2_85_1","doi-asserted-by":"crossref","unstructured":"Jazwa A Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets. 2010;11:1517\u20131531. doi:10.2174\/1389450111009011517","DOI":"10.2174\/1389450111009011517"},{"key":"e_1_3_2_86_1","doi-asserted-by":"crossref","unstructured":"Brouard S Otterbein LE Anrather J et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med. 2000;192:1015\u20131026. doi:10.1084\/jem.192.7.1015","DOI":"10.1084\/jem.192.7.1015"},{"key":"e_1_3_2_87_1","doi-asserted-by":"crossref","unstructured":"Otterbein LE Bach FH Alam J et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422\u2013428. doi:10.1038\/74680","DOI":"10.1038\/74680"},{"key":"e_1_3_2_88_1","doi-asserted-by":"crossref","unstructured":"Ryter SW Otterbein LE. Carbon monoxide in biology and medicine. Bioessays. 2004;26:270\u2013280. doi:10.1002\/bies.20005","DOI":"10.1002\/bies.20005"},{"key":"e_1_3_2_89_1","doi-asserted-by":"crossref","unstructured":"Ikegaya Y Saito H Abe K. High-frequency stimulation of the basolateral amygdala facilitates the induction of long-term potentiation in the dentate gyrus in vivo. Neurosci Res. 1995;22:203\u2013207. doi:10.1016\/0168-0102(95)00894-7","DOI":"10.1016\/0168-0102(95)00894-7"},{"key":"e_1_3_2_90_1","doi-asserted-by":"crossref","unstructured":"Alkadhi KA Al-Hijailan RS Malik K et al. Retrograde carbon monoxide is required for induction of long-term potentiation in rat superior cervical ganglion. J Neurosci. 2001;21:3515\u20133520. doi:10.1523\/JNEUROSCI.21-10-03515.2001","DOI":"10.1523\/JNEUROSCI.21-10-03515.2001"},{"key":"e_1_3_2_91_1","doi-asserted-by":"crossref","unstructured":"Cousar JL Lai Y Marco CD et al. Heme oxygenase 1 in cerebrospinal fluid from infants and children after severe traumatic brain injury. Dev Neurosci. 2006;28:342\u2013347. doi:10.1159\/000094160","DOI":"10.1159\/000094160"},{"key":"e_1_3_2_92_1","doi-asserted-by":"crossref","unstructured":"Dore S Sampei K Goto S et al. Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med. 1999;5:656\u2013663.","DOI":"10.1007\/BF03401984"},{"key":"e_1_3_2_93_1","doi-asserted-by":"crossref","unstructured":"Imuta N Hori O Kitao Y et al. Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis. Antioxid Redox Signal. 2007;9:543\u2013552. doi:10.1089\/ars.2006.1519","DOI":"10.1089\/ars.2006.1519"},{"key":"e_1_3_2_94_1","doi-asserted-by":"crossref","unstructured":"Munoz-Sanchez J Chanez-Cardenas ME. A review on hemeoxygenase-2: focus on cellular protection and oxygen response. Oxid Med Cell Longev. 2014;2014:604981. doi:10.1155\/2014\/604981","DOI":"10.1155\/2014\/604981"},{"key":"e_1_3_2_95_1","doi-asserted-by":"crossref","unstructured":"Schipper HM Cisse S Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol. 1995;37:758\u2013768. doi:10.1002\/ana.410370609","DOI":"10.1002\/ana.410370609"},{"key":"e_1_3_2_96_1","doi-asserted-by":"crossref","unstructured":"Schipper HM Song W. A heme oxygenase-1 transducer model of degenerative and developmental brain disorders. Int J Mol Sci. 2015;16:5400\u20135419. doi:10.3390\/ijms16035400","DOI":"10.3390\/ijms16035400"},{"key":"e_1_3_2_97_1","doi-asserted-by":"crossref","unstructured":"Barone E Di Domenico F Sultana R et al. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med. 2012;52:2292\u20132301. doi:10.1016\/j.freeradbiomed.2012.03.020","DOI":"10.1016\/j.freeradbiomed.2012.03.020"},{"key":"e_1_3_2_98_1","doi-asserted-by":"crossref","unstructured":"Mueller C Zhou W Vanmeter A et al. The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis. 2010;19:1081\u20131091. doi:10.3233\/JAD-2010-1303","DOI":"10.3233\/JAD-2010-1303"},{"key":"e_1_3_2_99_1","doi-asserted-by":"crossref","unstructured":"Cressatti M Schipper HM. Dysregulation of a heme oxygenase-synuclein axis in Parkinson disease. NeuroSci. 2022;3:284\u2013299. doi:10.3390\/neurosci3020020","DOI":"10.3390\/neurosci3020020"},{"key":"e_1_3_2_100_1","doi-asserted-by":"crossref","unstructured":"Schipper HM Liberman A Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol. 1998;150:60\u201368. doi:10.1006\/exnr.1997.6752","DOI":"10.1006\/exnr.1997.6752"},{"key":"e_1_3_2_101_1","doi-asserted-by":"crossref","unstructured":"Hirose W Ikematsu K Tsuda R. Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med (Tokyo). 2003;5(Suppl 1):S360\u2013S366. doi:10.1016\/s1344-6223(02)00133-5","DOI":"10.1016\/S1344-6223(02)00133-5"},{"key":"e_1_3_2_102_1","doi-asserted-by":"crossref","unstructured":"Vandiver M Snyder SH. Hydrogen sulfide: a gasotransmitter of clinical relevance. J Mol Med (Berl). 2012;90:255\u2013263. doi:10.1007\/s00109-012-0873-4","DOI":"10.1007\/s00109-012-0873-4"},{"key":"e_1_3_2_103_1","doi-asserted-by":"crossref","unstructured":"Szabo C. A timeline of hydrogen sulfide (H(2)S) research: from environmental toxin to biological mediator. Biochem Pharmacol. 2018;149:5\u201319. doi:10.1016\/j.bcp.2017.09.010","DOI":"10.1016\/j.bcp.2017.09.010"},{"key":"e_1_3_2_104_1","doi-asserted-by":"crossref","unstructured":"Cao X Bian JS. The role of hydrogen sulfide in renal system. Front Pharmacol. 2016;7:385. doi:10.3389\/fphar.2016.00385","DOI":"10.3389\/fphar.2016.00385"},{"key":"e_1_3_2_105_1","doi-asserted-by":"crossref","unstructured":"Sbodio JI Snyder SH Paul BD. Regulators of the transsulfuration pathway. Br J Pharmacol. 2019;176:583\u2013593. doi:10.1111\/bph.14446","DOI":"10.1111\/bph.14446"},{"key":"e_1_3_2_106_1","doi-asserted-by":"crossref","unstructured":"Singh S Banerjee R. PLP-dependent H(2)S biogenesis. Biochim Biophys Acta. 2011;1814:1518\u20131527. doi:10.1016\/j.bbapap.2011.02.004","DOI":"10.1016\/j.bbapap.2011.02.004"},{"key":"e_1_3_2_107_1","doi-asserted-by":"crossref","unstructured":"Carter RN Morton NM. Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology. J Pathol.. 2016;238:321\u2013332. doi:10.1002\/path.4659","DOI":"10.1002\/path.4659"},{"key":"e_1_3_2_108_1","doi-asserted-by":"crossref","unstructured":"Murphy B Bhattacharya R Mukherjee P. Hydrogen sulfide signaling in mitochondria and disease. FASEB J. 2019;33:13098\u201313125. doi:10.1096\/fj.201901304R","DOI":"10.1096\/fj.201901304R"},{"key":"e_1_3_2_109_1","doi-asserted-by":"crossref","unstructured":"Zhao K Li H Li S et al. Regulation of cystathionine gamma-lyase\/H(2)S system and its pathological implication. Front Biosci (Landmark Ed). 2014;19:1355\u20131369. doi:10.2741\/4286","DOI":"10.2741\/4286"},{"key":"e_1_3_2_110_1","doi-asserted-by":"crossref","unstructured":"Huang CW Moore PK. H2s synthesizing enzymes: biochemistry and molecular aspects. Handb Exp Pharmacol. 2015;230:3\u201325. doi:10.1007\/978-3-319-18144-8_1","DOI":"10.1007\/978-3-319-18144-8_1"},{"key":"e_1_3_2_111_1","doi-asserted-by":"crossref","unstructured":"Giuffre A Vicente JB. Hydrogen sulfide biochemistry and interplay with other gaseous mediators in mammalian physiology. Oxid Med Cell Longev. 2018;2018:6290931. doi:10.1155\/2018\/6290931","DOI":"10.1155\/2018\/6290931"},{"key":"e_1_3_2_112_1","doi-asserted-by":"crossref","unstructured":"Kabil O Banerjee R. Enzymology of H2S biogenesis decay and signaling. Antioxid Redox Signal. 2014;20:770\u2013782. doi:10.1089\/ars.2013.5339","DOI":"10.1089\/ars.2013.5339"},{"key":"e_1_3_2_113_1","doi-asserted-by":"crossref","unstructured":"Abe K Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16:1066\u20131071. doi:10.1523\/JNEUROSCI.16-03-01066.1996","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996"},{"key":"e_1_3_2_114_1","doi-asserted-by":"crossref","unstructured":"Robert K Vialard F Thiery E et al. Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J Histochem Cytochem. 2003;51:363\u2013371. doi:10.1177\/002215540305100311","DOI":"10.1177\/002215540305100311"},{"key":"e_1_3_2_115_1","doi-asserted-by":"crossref","unstructured":"Wang Z Liu DX Wang FW et al. L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS\/H(2)S pathway. Neuroscience. 2013;237:106\u2013117. doi:10.1016\/j.neuroscience.2012.12.057","DOI":"10.1016\/j.neuroscience.2012.12.057"},{"key":"e_1_3_2_116_1","doi-asserted-by":"crossref","unstructured":"Mishanina TV Libiad M Banerjee R. Biogenesis of reactive sulfur species for signaling by hydrogen sulfide oxidation pathways. Nat Chem Biol. 2015;11:457\u2013464. doi:10.1038\/nchembio.1834","DOI":"10.1038\/nchembio.1834"},{"key":"e_1_3_2_117_1","doi-asserted-by":"crossref","unstructured":"Zhang D Du J Tang C et al. H(2)S-induced sulfhydration: biological function and detection methodology. Front Pharmacol. 2017;8:608. doi:10.3389\/fphar.2017.00608","DOI":"10.3389\/fphar.2017.00608"},{"key":"e_1_3_2_118_1","doi-asserted-by":"crossref","unstructured":"Filipovic MR Zivanovic J Alvarez B et al. Chemical biology of H(2)S signaling through persulfidation. Chem Rev. 2018;118:1253\u20131337. doi:10.1021\/acs.chemrev.7b00205","DOI":"10.1021\/acs.chemrev.7b00205"},{"key":"e_1_3_2_119_1","doi-asserted-by":"crossref","unstructured":"Cirino G Szabo C Papapetropoulos A. Physiological roles of hydrogen sulfide in mammalian cells tissues and organs. Physiol Rev. 2023;103:31\u2013276. doi:10.1152\/physrev.00028.2021","DOI":"10.1152\/physrev.00028.2021"},{"key":"e_1_3_2_120_1","doi-asserted-by":"crossref","unstructured":"Nagpure BV Bian JS. Brain learning and memory: role of H2S in neurodegenerative diseases. Handb Exp Pharmacol. 2015;230:193\u2013215. doi:10.1007\/978-3-319-18144-8_10","DOI":"10.1007\/978-3-319-18144-8_10"},{"key":"e_1_3_2_121_1","doi-asserted-by":"crossref","unstructured":"Kimura Y Goto Y Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal. 2010;12:1\u201313. doi:10.1089\/ars.2008.2282","DOI":"10.1089\/ars.2008.2282"},{"key":"e_1_3_2_122_1","doi-asserted-by":"crossref","unstructured":"Kimura Y Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004;18:1165\u20131167. doi:10.1096\/fj.04-1815fje","DOI":"10.1096\/fj.04-1815fje"},{"key":"e_1_3_2_123_1","doi-asserted-by":"crossref","unstructured":"Zhang Q Yuan L Liu D et al. Hydrogen sulfide attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation. Pharmacol Res. 2014;84:32\u201344. doi:10.1016\/j.phrs.2014.04.009","DOI":"10.1016\/j.phrs.2014.04.009"},{"key":"e_1_3_2_124_1","doi-asserted-by":"crossref","unstructured":"Che X Fang Y Si X et al. The role of gaseous molecules in traumatic brain injury: an updated review. Front Neurosci. 2018;12:392. doi:10.3389\/fnins.2018.00392","DOI":"10.3389\/fnins.2018.00392"},{"key":"e_1_3_2_125_1","doi-asserted-by":"crossref","unstructured":"Zhang M Shan H Chang P et al. Hydrogen sulfide offers neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice. PLoS One. 2014;9:e87241. doi:10.1371\/journal.pone.0087241","DOI":"10.1371\/journal.pone.0087241"},{"key":"e_1_3_2_126_1","doi-asserted-by":"crossref","unstructured":"Yu YP Chi XL Liu LJ. A hypothesis: hydrogen sulfide might be neuroprotective against subarachnoid hemorrhage induced brain injury. ScientificWorldJournal. 2014;2014:432318. doi:10.1155\/2014\/432318","DOI":"10.1155\/2014\/432318"},{"key":"e_1_3_2_127_1","doi-asserted-by":"crossref","unstructured":"Munteanu C Galaction AI Onose G et al. The Janus face of oxidative stress and hydrogen sulfide: insights into neurodegenerative disease pathogenesis. Antioxidants (Basel). 2025;14; doi:10.3390\/antiox14030360","DOI":"10.3390\/antiox14030360"},{"key":"e_1_3_2_128_1","doi-asserted-by":"crossref","unstructured":"Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol. 2002;26:13\u201319. doi:10.1385\/MN:26:1:013","DOI":"10.1385\/MN:26:1:013"},{"key":"e_1_3_2_129_1","doi-asserted-by":"crossref","unstructured":"Tu FP Li JX Li Q et al. Effects of hydrogen sulfide on cognitive dysfunction and NR2B in rats. J Surg Res. 2016;205:426\u2013431. doi:10.1016\/j.jss.2016.06.071","DOI":"10.1016\/j.jss.2016.06.071"},{"key":"e_1_3_2_130_1","doi-asserted-by":"crossref","unstructured":"Wang M Tang JJ Wang LX et al. Hydrogen sulfide enhances adult neurogenesis in a mouse model of Parkinson's disease. Neural Regen Res. 2021;16:1353\u20131358. doi:10.4103\/1673-5374.301026","DOI":"10.4103\/1673-5374.301026"},{"key":"e_1_3_2_131_1","doi-asserted-by":"crossref","unstructured":"Cakmak YO. Coffee consumption smoking and Parkinson's disease? The beneficial role of hydrogen sulfide. Mov Disord.2016;31:429. doi:10.1002\/mds.26526","DOI":"10.1002\/mds.26526"},{"key":"e_1_3_2_132_1","doi-asserted-by":"crossref","unstructured":"Siracusa R Voltarelli VA Salinaro AT et al. NO CO and H(2)S: A trinacrium of bioactive gases in the brain. Biochem Pharmacol. 2022;202:115122. doi:10.1016\/j.bcp.2022.115122","DOI":"10.1016\/j.bcp.2022.115122"},{"key":"e_1_3_2_133_1","doi-asserted-by":"crossref","unstructured":"Huang YQ Jin HF Zhang H et al. Interaction among hydrogen sulfide and other gasotransmitters in mammalian physiology and pathophysiology. Adv Exp Med Biol. 2021;1315:205\u2013236. doi:10.1007\/978-981-16-0991-6_9","DOI":"10.1007\/978-981-16-0991-6_9"},{"key":"e_1_3_2_134_1","doi-asserted-by":"crossref","unstructured":"Shefa U Yeo SG Kim MS et al. Role of gasotransmitters in oxidative stresses neuroinflammation and neuronal repair. Biomed Res Int. 2017;2017:1689341. doi:10.1155\/2017\/1689341","DOI":"10.1155\/2017\/1689341"},{"key":"e_1_3_2_135_1","doi-asserted-by":"crossref","unstructured":"Hu LF Wong PT Moore PK et al. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem. 2007;100:1121\u20131128. doi:10.1111\/j.1471-4159.2006.04283.x","DOI":"10.1111\/j.1471-4159.2006.04283.x"},{"key":"e_1_3_2_136_1","doi-asserted-by":"crossref","unstructured":"Wang Y Jia J Ao G et al. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia. J Neurochem. 2014;129:827\u2013838. doi:10.1111\/jnc.12695","DOI":"10.1111\/jnc.12695"},{"key":"e_1_3_2_137_1","doi-asserted-by":"crossref","unstructured":"Kumar M Sandhir R. Hydrogen sulfide suppresses homocysteine-induced glial activation and inflammatory response. Nitric Oxide. 2019;90:15\u201328. doi:10.1016\/j.niox.2019.05.008","DOI":"10.1016\/j.niox.2019.05.008"},{"key":"e_1_3_2_138_1","doi-asserted-by":"crossref","unstructured":"Jia J Xiao Y Wang W et al. Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress. Neurochem Int. 2013;62:1072\u20131078. doi:10.1016\/j.neuint.2013.04.001","DOI":"10.1016\/j.neuint.2013.04.001"},{"key":"e_1_3_2_139_1","doi-asserted-by":"crossref","unstructured":"Ohno K Okuda K Uehara T. Endogenous S-sulfhydration of PTEN helps protect against modification by nitric oxide. Biochem Biophys Res Commun. 2015;456:245\u2013249. doi:10.1016\/j.bbrc.2014.11.066","DOI":"10.1016\/j.bbrc.2014.11.066"},{"key":"e_1_3_2_140_1","doi-asserted-by":"crossref","unstructured":"Han Y Qin J Chang X et al. Hydrogen sulfide and carbon monoxide are in synergy with each other in the pathogenesis of recurrent febrile seizures. Cell Mol Neurobiol. 2006;26:101\u2013107. doi:10.1007\/s10571-006-8848-z","DOI":"10.1007\/s10571-006-8848-z"},{"key":"e_1_3_2_141_1","doi-asserted-by":"crossref","unstructured":"Han Y Qin J Chang X et al. Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats. Biochem Biophys Res Commun. 2005;327:431\u2013436. doi:10.1016\/j.bbrc.2004.12.028","DOI":"10.1016\/j.bbrc.2004.12.028"},{"key":"e_1_3_2_142_1","doi-asserted-by":"crossref","unstructured":"Yang ZX Qin J. Interaction between endogenous nitric oxide and carbon monoxide in the pathogenesis of recurrent febrile seizures. Biochem Biophys Res Commun. 2004;315:349\u2013355. doi:10.1016\/j.bbrc.2004.01.061","DOI":"10.1016\/j.bbrc.2004.01.061"},{"key":"e_1_3_2_143_1","doi-asserted-by":"crossref","unstructured":"Kabe Y Yamamoto T Kajimura M et al. Cystathionine beta-synthase and PGRMC1 as CO sensors. Free Radic Biol Med. 2016;99:333\u2013344. doi:10.1016\/j.freeradbiomed.2016.08.025","DOI":"10.1016\/j.freeradbiomed.2016.08.025"},{"key":"e_1_3_2_144_1","doi-asserted-by":"crossref","unstructured":"Morikawa T Kajimura M Nakamura T et al. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. Proc Natl Acad Sci U S A. 2012;109:1293\u20131298. doi:10.1073\/pnas.1119658109","DOI":"10.1073\/pnas.1119658109"},{"key":"e_1_3_2_145_1","doi-asserted-by":"crossref","unstructured":"Vicente JB Colaco HG Mendes MI et al. NO* binds human cystathionine beta-synthase quickly and tightly. J Biol Chem. 2014;289:8579\u20138587. doi:10.1074\/jbc.M113.507533","DOI":"10.1074\/jbc.M113.507533"},{"key":"e_1_3_2_146_1","doi-asserted-by":"crossref","unstructured":"Eto K Kimura H. A novel enhancing mechanism for hydrogen sulfide-producing activity of cystathionine beta-synthase. J Biol Chem. 2002;277:42680\u201342685. doi:10.1074\/jbc.M205835200","DOI":"10.1074\/jbc.M205835200"},{"key":"e_1_3_2_147_1","doi-asserted-by":"crossref","unstructured":"Coletti R de Lima JBM Vechiato FMV et al. Nitric oxide acutely modulates hypothalamic and neurohypophyseal carbon monoxide and hydrogen sulphide production to control vasopressin oxytocin and atrial natriuretic peptide release in rats. J Neuroendocrinol. 2019;31:e12686. doi:10.1111\/jne.12686","DOI":"10.1111\/jne.12686"},{"key":"e_1_3_2_148_1","doi-asserted-by":"crossref","unstructured":"Liu W Wang D Liu K et al. Nrf2 as a converging node for cellular signaling pathways of gasotransmitters. Med Hypotheses. 2012;79:308\u2013310. doi:10.1016\/j.mehy.2012.05.016","DOI":"10.1016\/j.mehy.2012.05.016"},{"key":"e_1_3_2_149_1","doi-asserted-by":"crossref","unstructured":"Paul BD Snyder SH. Modes of physiologic H2S signaling in the brain and peripheral tissues. Antioxid Redox Signal. 2015;22:411\u2013423. doi:10.1089\/ars.2014.5917","DOI":"10.1089\/ars.2014.5917"},{"key":"e_1_3_2_150_1","doi-asserted-by":"crossref","unstructured":"Paul BD Snyder SH. Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol. 2018;149:101\u2013109. doi:10.1016\/j.bcp.2017.11.019","DOI":"10.1016\/j.bcp.2017.11.019"},{"key":"e_1_3_2_151_1","doi-asserted-by":"crossref","unstructured":"Zhang J Shi C Wang H et al. Hydrogen sulfide protects against cell damage through modulation of PI3K\/Akt\/Nrf2 signaling. Int J Biochem Cell Biol. 2019;117:105636. doi:10.1016\/j.biocel.2019.105636","DOI":"10.1016\/j.biocel.2019.105636"},{"key":"e_1_3_2_152_1","doi-asserted-by":"crossref","unstructured":"Wang B Cao W Biswal S et al. Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke. 2011;42:2605\u20132610. doi:10.1161\/STROKEAHA.110.607101","DOI":"10.1161\/STROKEAHA.110.607101"},{"key":"e_1_3_2_153_1","doi-asserted-by":"crossref","unstructured":"Estrada C Murillo-Carretero M. Nitric oxide and adult neurogenesis in health and disease. Neuroscientist. 2005;11:294\u2013307. doi:10.1177\/1073858404273850","DOI":"10.1177\/1073858404273850"},{"key":"e_1_3_2_154_1","doi-asserted-by":"crossref","unstructured":"Moreno-Lopez B Romero-Grimaldi C Noval JA et al. Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb. J Neurosci. 2004;24:85\u201395. doi:10.1523\/JNEUROSCI.1574-03.2004","DOI":"10.1523\/JNEUROSCI.1574-03.2004"},{"key":"e_1_3_2_155_1","doi-asserted-by":"crossref","unstructured":"Packer MA Stasiv Y Benraiss A et al. Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A. 2003;100:9566\u20139571. doi:10.1073\/pnas.1633579100","DOI":"10.1073\/pnas.1633579100"},{"key":"e_1_3_2_156_1","doi-asserted-by":"crossref","unstructured":"Zhu DY Liu SH Sun HS et al. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J Neurosci. 2003;23:223\u2013229. doi:10.1523\/JNEUROSCI.23-01-00223.2003","DOI":"10.1523\/JNEUROSCI.23-01-00223.2003"},{"key":"e_1_3_2_157_1","doi-asserted-by":"crossref","unstructured":"Carreira BP Morte MI Inacio A et al. Nitric oxide stimulates the proliferation of neural stem cells bypassing the epidermal growth factor receptor. Stem Cells. 2010;28:1219\u20131230. doi:10.1002\/stem.444","DOI":"10.1002\/stem.444"},{"key":"e_1_3_2_158_1","doi-asserted-by":"crossref","unstructured":"Luo CX Zhu XJ Zhou QG et al. Reduced neuronal nitric oxide synthase is involved in ischemia-induced hippocampal neurogenesis by up-regulating inducible nitric oxide synthase expression. J Neurochem. 2007;103:1872\u20131882. doi:10.1111\/j.1471-4159.2007.04915.x","DOI":"10.1111\/j.1471-4159.2007.04915.x"},{"key":"e_1_3_2_159_1","doi-asserted-by":"crossref","unstructured":"Jiang W Xiao L Wang JC et al. Effects of nitric oxide on dentate gyrus cell proliferation after seizures induced by pentylenetrazol in the adult rat brain. Neurosci Lett. 2004;367:344\u2013348. doi:10.1016\/j.neulet.2004.06.031","DOI":"10.1016\/j.neulet.2004.06.031"},{"key":"e_1_3_2_160_1","doi-asserted-by":"crossref","unstructured":"Santos AI Carreira BP Izquierdo-Alvarez A et al. S-Nitrosylation of Ras mediates nitric oxide-dependent post-injury neurogenesis in a seizure model. Antioxid Redox Signal. 2018;28:15\u201330. doi:10.1089\/ars.2016.6858","DOI":"10.1089\/ars.2016.6858"},{"key":"e_1_3_2_161_1","doi-asserted-by":"crossref","unstructured":"Carreira BP Santos DF Santos AI et al. Nitric oxide regulates neurogenesis in the hippocampus following seizures. Oxid Med Cell Longev. 2015;2015:451512. doi:10.1155\/2015\/451512","DOI":"10.1155\/2015\/451512"},{"key":"e_1_3_2_162_1","doi-asserted-by":"crossref","unstructured":"Santos AI Lourenco AS Simao S et al. Identification of new targets of S-nitrosylation in neural stem cells by thiol redox proteomics. Redox Biol. 2020;32:101457. doi:10.1016\/j.redox.2020.101457","DOI":"10.1016\/j.redox.2020.101457"},{"key":"e_1_3_2_163_1","doi-asserted-by":"crossref","unstructured":"Lu D Mahmood A Zhang R et al. Upregulation of neurogenesis and reduction in functional deficits following administration of DEtA\/NONOate a nitric oxide donor after traumatic brain injury in rats. J Neurosurg. 2003;99:351\u2013361. doi:10.3171\/jns.2003.99.2.0351","DOI":"10.3171\/jns.2003.99.2.0351"},{"key":"e_1_3_2_164_1","doi-asserted-by":"crossref","unstructured":"Zhang R Zhang L Zhang Z et al. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann Neurol. 2001;50:602\u2013611. doi:10.1002\/ana.1249","DOI":"10.1002\/ana.1249"},{"key":"e_1_3_2_165_1","doi-asserted-by":"crossref","unstructured":"Jung E Koh SH Yoo M et al. Regenerative potential of carbon monoxide in adult neural circuits of the central nervous system. Int J Mol Sci. 2020;21. doi:10.3390\/ijms21072273","DOI":"10.3390\/ijms21072273"},{"key":"e_1_3_2_166_1","doi-asserted-by":"crossref","unstructured":"Nada SE Tulsulkar J Shah ZA. Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761(R)) after permanent ischemic stroke in mice. Mol Neurobiol. 2014;49:945\u2013956. doi:10.1007\/s12035-013-8572-x","DOI":"10.1007\/s12035-013-8572-x"},{"key":"e_1_3_2_167_1","doi-asserted-by":"crossref","unstructured":"Choi YK Maki T Mandeville ET et al. Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury. Nat Med. 2016;22:1335\u20131341. doi:10.1038\/nm.4188","DOI":"10.1038\/nm.4188"},{"key":"e_1_3_2_168_1","doi-asserted-by":"crossref","unstructured":"Almeida AS Soares NL Vieira M et al. Carbon monoxide releasing molecule-A1 (CORM-A1) improves neurogenesis: increase of neuronal differentiation yield by preventing cell death. PLoS One. 2016;11:e0154781. doi:10.1371\/journal.pone.0154781","DOI":"10.1371\/journal.pone.0154781"},{"key":"e_1_3_2_169_1","doi-asserted-by":"crossref","unstructured":"Noraberg J Poulsen FR Blaabjerg M et al. Organotypic hippocampal slice cultures for studies of brain damage neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord. 2005;4:435\u2013452. doi:10.2174\/1568007054546108","DOI":"10.2174\/1568007054546108"},{"key":"e_1_3_2_170_1","doi-asserted-by":"crossref","unstructured":"Almeida AS Soares NL Sequeira CO et al. Improvement of neuronal differentiation by carbon monoxide: role of pentose phosphate pathway. Redox Biol. 2018;17:338\u2013347. doi:10.1016\/j.redox.2018.05.004","DOI":"10.1016\/j.redox.2018.05.004"},{"key":"e_1_3_2_171_1","doi-asserted-by":"crossref","unstructured":"Dreyer-Andersen N Almeida AS Jensen P et al. Intermittent low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells. PLoS One. 2018;13:e0191207. doi:10.1371\/journal.pone.0191207","DOI":"10.1371\/journal.pone.0191207"},{"key":"e_1_3_2_172_1","doi-asserted-by":"crossref","unstructured":"Ochi S Sekiya K Abe N et al. Neural precursor cells are decreased in the hippocampus of the delayed carbon monoxide encephalopathy rat model. Sci Rep. 2021;11:6244. doi:10.1038\/s41598-021-85860-9","DOI":"10.1038\/s41598-021-85860-9"},{"key":"e_1_3_2_173_1","doi-asserted-by":"crossref","unstructured":"Tarui T Fukami K Nagasawa K et al. Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide. J Neurochem. 2010;114:512\u2013519. doi:10.1111\/j.1471-4159.2010.06774.x","DOI":"10.1111\/j.1471-4159.2010.06774.x"},{"key":"e_1_3_2_174_1","doi-asserted-by":"crossref","unstructured":"Nagasawa K Tarui T Yoshida S et al. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels. J Neurochem. 2009;108:676\u2013684. doi:10.1111\/j.1471-4159.2008.05808.x","DOI":"10.1111\/j.1471-4159.2008.05808.x"},{"key":"e_1_3_2_175_1","doi-asserted-by":"crossref","unstructured":"Fukami K Kawabata A. Hydrogen sulfide and neuronal differentiation: focus on Ca2+ channels. Nitric Oxide. 2015;46:50\u201354. doi:10.1016\/j.niox.2015.02.001","DOI":"10.1016\/j.niox.2015.02.001"},{"key":"e_1_3_2_176_1","doi-asserted-by":"crossref","unstructured":"Fukami K Fukami K Sekiguchi F et al. Hydrogen sulfide and T-type Ca2+ channels in pain processing neuronal differentiation and neuroendocrine secretion. Pharmacology. 2017;99:196\u2013203. doi:10.1159\/000449449","DOI":"10.1159\/000449449"},{"key":"e_1_3_2_177_1","doi-asserted-by":"crossref","unstructured":"Liu D Wang Z Zhan J et al. Hydrogen sulfide promotes proliferation and neuronal differentiation of neural stem cells and protects hypoxia-induced decrease in hippocampal neurogenesis. Pharmacol Biochem Behav. 2014;116:55\u201363. doi:10.1016\/j.pbb.2013.11.009","DOI":"10.1016\/j.pbb.2013.11.009"},{"key":"e_1_3_2_178_1","doi-asserted-by":"crossref","unstructured":"Mohseni F Bagheri F Rafaiee R et al. Hydrogen sulfide improves spatial memory impairment via increases of BDNF expression and hippocampal neurogenesis following early postnatal alcohol exposure. Physiol Behav. 2020;215:112784. doi:10.1016\/j.physbeh.2019.112784","DOI":"10.1016\/j.physbeh.2019.112784"},{"key":"e_1_3_2_179_1","doi-asserted-by":"crossref","unstructured":"Rodkin S Nwosu C Sannikov A et al. The role of gasotransmitter-dependent signaling mechanisms in apoptotic cell death in cardiovascular rheumatic kidney and neurodegenerative diseases and mental disorders. Int J Mol Sci. 2023;24. doi:10.3390\/ijms24076014","DOI":"10.3390\/ijms24076014"},{"key":"e_1_3_2_180_1","doi-asserted-by":"crossref","unstructured":"Yang G Sener A Ji Y et al. Gasotransmitters in biology and medicine: molecular mechanisms and drug targets. Oxid Med Cell Longev. 2016;2016:4627308. doi:10.1155\/2016\/4627308","DOI":"10.1155\/2016\/4627308"},{"key":"e_1_3_2_181_1","doi-asserted-by":"crossref","unstructured":"Panthi S Manandhar S Gautam K. Hydrogen sulfide nitric oxide and neurodegenerative disorders. Transl Neurodegener. 2018;7:3. doi:10.1186\/s40035-018-0108-x","DOI":"10.1186\/s40035-018-0108-x"},{"key":"e_1_3_2_182_1","doi-asserted-by":"crossref","unstructured":"Pawar R Pandey D Naqvi S et al. Critical role of hydrogen sulfide in the management of neurodegenerative disease. Nitric Oxide. 2025;154:77\u201385. doi:10.1016\/j.niox.2024.11.006","DOI":"10.1016\/j.niox.2024.11.006"},{"key":"e_1_3_2_183_1","doi-asserted-by":"crossref","unstructured":"Dorheim MA Tracey WR Pollock JS et al. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun. 1994;205:659\u2013665. doi:10.1006\/bbrc.1994.2716","DOI":"10.1006\/bbrc.1994.2716"},{"key":"e_1_3_2_184_1","doi-asserted-by":"crossref","unstructured":"Luth HJ Munch G Arendt T. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res. 2002;953:135\u2013143. doi:10.1016\/s0006-8993(02)03280-8","DOI":"10.1016\/S0006-8993(02)03280-8"},{"key":"e_1_3_2_185_1","doi-asserted-by":"crossref","unstructured":"Good PF Werner P Hsu A et al. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol. 1996;149:21\u201328.","DOI":"10.1007\/BF02815201"},{"key":"e_1_3_2_186_1","doi-asserted-by":"crossref","unstructured":"Selley ML. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol Aging. 2003;24:903\u2013907. doi:10.1016\/s0197-4580(03)00007-1","DOI":"10.1016\/S0197-4580(03)00007-1"},{"key":"e_1_3_2_187_1","doi-asserted-by":"crossref","unstructured":"Venturelli M Pedrinolla A Boscolo Galazzo I et al. Impact of nitric oxide bioavailability on the progressive cerebral and peripheral circulatory impairments during aging and Alzheimer's disease. Front Physiol. 2018;9:169. doi:10.3389\/fphys.2018.00169","DOI":"10.3389\/fphys.2018.00169"},{"key":"e_1_3_2_188_1","doi-asserted-by":"crossref","unstructured":"Hurtado MO Kohler I de Lange EC. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies. Bioanalysis. 2018;10:1525\u20131546. doi:10.4155\/bio-2018-0135","DOI":"10.4155\/bio-2018-0135"},{"key":"e_1_3_2_189_1","doi-asserted-by":"crossref","unstructured":"Fleszar MG Wisniewski J Zboch M et al. Targeted metabolomic analysis of nitric oxide\/L-arginine pathway metabolites in dementia: association with pathology severity and structural brain changes. Sci Rep. 2019;9:13764. doi:10.1038\/s41598-019-50205-0","DOI":"10.1038\/s41598-019-50205-0"},{"key":"e_1_3_2_190_1","doi-asserted-by":"crossref","unstructured":"Hunot S Boissiere F Faucheux B et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience. 1996;72:355\u2013363. doi:10.1016\/0306-4522(95)00578-1","DOI":"10.1016\/0306-4522(95)00578-1"},{"key":"e_1_3_2_191_1","doi-asserted-by":"crossref","unstructured":"Eve DJ Nisbet AP Kingsbury AE et al. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res Mol Brain Res. 1998;63:62\u201371. doi:10.1016\/s0169-328x(98)00259-9","DOI":"10.1016\/S0169-328X(98)00259-9"},{"key":"e_1_3_2_192_1","doi-asserted-by":"crossref","unstructured":"Shukla R Rajani M Srivastava N et al. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease. Int J Neurosci. 2006;116:1391\u20131402. doi:10.1080\/00207450500513989","DOI":"10.1080\/00207450500513989"},{"key":"e_1_3_2_193_1","unstructured":"Kouti L Noroozian M Akhondzadeh S et al. Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci. 2013;17:964\u2013970."},{"key":"e_1_3_2_194_1","doi-asserted-by":"crossref","unstructured":"Cubukcu HC Yurtdas M Durak ZE et al. Oxidative and nitrosative stress in serum of patients with Parkinson's disease. Neurol Sci. 2016;37:1793\u20131798. doi:10.1007\/s10072-016-2663-1","DOI":"10.1007\/s10072-016-2663-1"},{"key":"e_1_3_2_195_1","doi-asserted-by":"crossref","unstructured":"Tuncel D Inanc Tolun F Toru I. Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease. Mediators Inflamm. 2009;2009:132464. doi:10.1155\/2009\/132464","DOI":"10.1155\/2009\/132464"},{"key":"e_1_3_2_196_1","doi-asserted-by":"crossref","unstructured":"Rathnayake D Chang T Udagama P. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study. BMC Neurol. 2019;19:56. doi:10.1186\/s12883-019-1286-6","DOI":"10.1186\/s12883-019-1286-6"},{"key":"e_1_3_2_197_1","doi-asserted-by":"crossref","unstructured":"Si Z Wang X. The neuroprotective and neurodegeneration effects of heme oxygenase-1 in Alzheimer's disease. J Alzheimers Dis. 2020;78:1259\u20131272. doi:10.3233\/JAD-200720","DOI":"10.3233\/JAD-200720"},{"key":"e_1_3_2_198_1","doi-asserted-by":"crossref","unstructured":"Schipper HM Song W Tavitian A et al. The sinister face of heme oxygenase-1 in brain aging and disease. Prog Neurobiol. 2019;172:40\u201370. doi:10.1016\/j.pneurobio.2018.06.008","DOI":"10.1016\/j.pneurobio.2018.06.008"},{"key":"e_1_3_2_199_1","doi-asserted-by":"crossref","unstructured":"Fernandez-Mendivil C Arreola MA Hohsfield LA et al. Aging and progression of beta-amyloid pathology in Alzheimer's disease correlates with microglial heme-oxygenase-1 overexpression. Antioxidants (Basel). 2020;9. doi:10.3390\/antiox9070644","DOI":"10.3390\/antiox9070644"},{"key":"e_1_3_2_200_1","doi-asserted-by":"crossref","unstructured":"Anthony SG Schipper HM Tavares R et al. Stress protein expression in the Alzheimer-diseased choroid plexus. J Alzheimers Dis. 2003;5:171\u2013177. doi:10.3233\/jad-2003-5301","DOI":"10.3233\/JAD-2003-5301"},{"key":"e_1_3_2_201_1","doi-asserted-by":"crossref","unstructured":"Schipper HM Chertkow H Mehindate K et al. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology. 2000;54:1297\u20131304. doi:10.1212\/wnl.54.6.1297","DOI":"10.1212\/WNL.54.6.1297"},{"key":"e_1_3_2_202_1","doi-asserted-by":"crossref","unstructured":"Mateo I Infante J Sanchez-Juan P et al. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurol Scand. 2010;121:136\u2013138. doi:10.1111\/j.1600-0404.2009.01261.x","DOI":"10.1111\/j.1600-0404.2009.01261.x"},{"key":"e_1_3_2_203_1","doi-asserted-by":"crossref","unstructured":"Sun W Zheng J Ma J et al. Increased plasma heme oxygenase-1 levels in patients with early-stage Parkinson's disease. Front Aging Neurosci. 2021;13:621508. doi:10.3389\/fnagi.2021.621508","DOI":"10.3389\/fnagi.2021.621508"},{"key":"e_1_3_2_204_1","doi-asserted-by":"crossref","unstructured":"Song W Kothari V Velly AM et al. Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease. Mov Disord. 2018;33:583\u2013591. doi:10.1002\/mds.27328","DOI":"10.1002\/mds.27328"},{"key":"e_1_3_2_205_1","doi-asserted-by":"crossref","unstructured":"Galindez JM Juwara L Cressatti M et al. Salivary heme oxygenase-1: a potential biomarker for central neurodegeneration. J Cent Nerv Syst Dis. 2021;13:11795735211029114. doi:10.1177\/11795735211029114","DOI":"10.1177\/11795735211029114"},{"key":"e_1_3_2_206_1","unstructured":"Liu XQ Liu XQ Jiang P et al. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof]. Zhonghua Yi Xue Za Zhi. 2008;88:2246\u20132249."},{"key":"e_1_3_2_207_1","doi-asserted-by":"crossref","unstructured":"Eto K Asada T Arima K et al. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun. 2002;293:1485\u20131488. doi:10.1016\/S0006-291X(02)00422-9","DOI":"10.1016\/S0006-291X(02)00422-9"},{"key":"e_1_3_2_208_1","doi-asserted-by":"crossref","unstructured":"Zhang JY Ma S Liu X et al. Activating transcription factor 6 regulates cystathionine to increase autophagy and restore memory in Alzheimer' s disease model mice. Biochem Biophys Res Commun. 2022;615:109\u2013115. doi:10.1016\/j.bbrc.2022.05.053","DOI":"10.1016\/j.bbrc.2022.05.053"},{"key":"e_1_3_2_209_1","doi-asserted-by":"crossref","unstructured":"Disbrow E Stokes KY Ledbetter C et al. Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias. Alzheimers Dement. 2021;17:1391\u20131402. doi:10.1002\/alz.12305","DOI":"10.1002\/alz.12305"},{"key":"e_1_3_2_210_1","doi-asserted-by":"crossref","unstructured":"Reekes TH Ledbetter CR Alexander JS et al. Elevated plasma sulfides are associated with cognitive dysfunction and brain atrophy in human Alzheimer's disease and related dementias. Redox Biol. 2023;62:102633. doi:10.1016\/j.redox.2023.102633","DOI":"10.1016\/j.redox.2023.102633"},{"key":"e_1_3_2_211_1","doi-asserted-by":"crossref","unstructured":"Greco V Neri C Pieragostino D et al. Investigating different forms of hydrogen sulfide in cerebrospinal fluid of various neurological disorders. Metabolites. 2021;11; doi:10.3390\/metabo11030152","DOI":"10.3390\/metabo11030152"},{"key":"e_1_3_2_212_1","doi-asserted-by":"crossref","unstructured":"Vandiver MS Paul BD Xu R et al. Sulfhydration mediates neuroprotective actions of parkin. Nat Commun. 2013;4:1626. doi:10.1038\/ncomms2623","DOI":"10.1038\/ncomms2623"},{"key":"e_1_3_2_213_1","doi-asserted-by":"crossref","unstructured":"McCarty MF O'Keefe JH DiNicolantonio JJ. A diet rich in taurine : cysteine folate B(12) and betaine may lessen risk for Alzheimer's disease by boosting brain synthesis of hydrogen sulfide. Med Hypotheses. 2019;132:109356. doi:10.1016\/j.mehy.2019.109356","DOI":"10.1016\/j.mehy.2019.109356"},{"key":"e_1_3_2_214_1","doi-asserted-by":"crossref","unstructured":"Aamer H Tariq M Yawar M et al. Exploring taurine's potential in Alzheimer's treatment: a comprehensive review. Cureus. 2024;16:e60997. doi:10.7759\/cureus.60997","DOI":"10.7759\/cureus.60997"},{"key":"e_1_3_2_215_1","doi-asserted-by":"crossref","unstructured":"Alipourfard F Shajiee H Nazari-Serenjeh F et al. Betaine attenuates oxidative stress and cognitive dysfunction in an amyloid beta-induced rat model of Alzheimer's disease. Res Pharm Sci. 2023;18:270\u2013278. doi:10.4103\/1735-5362.371583","DOI":"10.4103\/1735-5362.371583"},{"key":"e_1_3_2_216_1","doi-asserted-by":"crossref","unstructured":"Jangra A Gola P Singh J et al. Emergence of taurine as a therapeutic agent for neurological disorders. Neural Regen Res. 2024;19:62\u201368. doi:10.4103\/1673-5374.374139","DOI":"10.4103\/1673-5374.374139"},{"key":"e_1_3_2_217_1","doi-asserted-by":"crossref","unstructured":"Reza-Zaldivar EE Jacobo-Velazquez DA. Comprehensive review of nutraceuticals against cognitive decline associated with Alzheimer's disease. ACS Omega 2023;8:35499\u201335522. doi:10.1021\/acsomega.3c04855","DOI":"10.1021\/acsomega.3c04855"},{"key":"e_1_3_2_218_1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/B978-0-443-18951-7.00024-4","volume-title":"Nutraceutical fruits and foods for neurodegenerative disorders","author":"Kapoor D","year":"2024","unstructured":"Kapoor D, Sharma D, Sharma JB, et al. Chapter 23 \u2013 nutraceuticals in the management of Parkinson\u2019s disease and dementia. In: Keservani RK, Kesharwani RK, Emerald M, et al., editors. Nutraceutical fruits and foods for neurodegenerative disorders. Academic Press; 2024. p. 441\u2013466."},{"key":"e_1_3_2_219_1","doi-asserted-by":"crossref","unstructured":"Sadhukhan P Saha S Dutta S et al. Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease. Pharmacol Res. 2018;129:100\u2013114. doi:10.1016\/j.phrs.2017.11.028","DOI":"10.1016\/j.phrs.2017.11.028"},{"key":"e_1_3_2_220_1","doi-asserted-by":"crossref","unstructured":"Chiu HF Venkatakrishnan K Wang CK. The role of nutraceuticals as a complementary therapy against various neurodegenerative diseases: A mini-review. J Tradit Complement Med. 2020;10:434\u2013439. doi:10.1016\/j.jtcme.2020.03.008","DOI":"10.1016\/j.jtcme.2020.03.008"},{"key":"e_1_3_2_221_1","doi-asserted-by":"crossref","unstructured":"Sidiropoulou GA Metaxas A Kourti M. Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action. Front Endocrinol (Lausanne). 2023;14:1217730. doi:10.3389\/fendo.2023.1217730","DOI":"10.3389\/fendo.2023.1217730"},{"key":"e_1_3_2_222_1","doi-asserted-by":"crossref","unstructured":"Wang Y Gao L Chen J et al. Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson's disease. Front Pharmacol. 2021;12:757161. doi:10.3389\/fphar.2021.757161","DOI":"10.3389\/fphar.2021.757161"},{"key":"e_1_3_2_223_1","unstructured":"Cakmak YO. Rotorua hydrogen sulphide and Parkinson's disease-A possible beneficial link? N Z Med J. 2017;130:123\u2013125."},{"key":"e_1_3_2_224_1","unstructured":"Nandula PS Shah SD. Persistent pulmonary hypertension of the Newborn. BTI - StatPearls."},{"key":"e_1_3_2_225_1","doi-asserted-by":"crossref","unstructured":"Tettey A Jiang Y Li X et al. Therapy for pulmonary arterial hypertension: glance on nitric oxide pathway. Front Pharmacol. 2021;12:767002. doi:10.3389\/fphar.2021.767002","DOI":"10.3389\/fphar.2021.767002"},{"key":"e_1_3_2_226_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/9781119783435.ch30","volume-title":"Carbon monoxide in drug discovery","author":"Gomperts E","year":"2022","unstructured":"Gomperts E, Gompertsd A, Levy H. Clinical trials of low-dose carbon monoxide. In: Carbon monoxide in drug discovery; 2022. p. 511\u2013527."},{"key":"e_1_3_2_227_1","doi-asserted-by":"crossref","unstructured":"Siracusa R Schaufler A Calabrese V et al. Carbon monoxide: from poison to clinical trials. Trends Pharmacol Sci. 2021;42:329\u2013339. doi:10.1016\/j.tips.2021.02.003","DOI":"10.1016\/j.tips.2021.02.003"},{"key":"e_1_3_2_228_1","doi-asserted-by":"crossref","unstructured":"Fredenburgh LE Perrella MA Barragan-Bradford D et al. A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS. JCI Insight. 2018;3; doi:10.1172\/jci.insight.124039","DOI":"10.1172\/jci.insight.124039"},{"key":"e_1_3_2_229_1","doi-asserted-by":"crossref","unstructured":"Rosas IO Goldberg HJ Collard HR et al. A phase II clinical trial of low-dose inhaled carbon monoxide in idiopathic pulmonary fibrosis. Chest. 2018;153:94\u2013104. doi:10.1016\/j.chest.2017.09.052","DOI":"10.1016\/j.chest.2017.09.052"},{"key":"e_1_3_2_230_1","unstructured":"A Phase 1 Open Labeled Single Ascending Dose Followed by Multiple Dose Safety and Pharmacokinetic Study of HBI-002 Carbon Monoxide Oral Liquid Drug Product in Healthy Adult Volunteers [Internet]. ClinicalTrials.gov. 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03926819"},{"key":"e_1_3_2_231_1","unstructured":"An Open Label Phase 2a Ascending Multiple Dose Safety Efficacy and Pharmacokinetic Study of HBI-002 Carbon Monoxide Oral Liquid Drug Product in Adolescents and Adults With Sickle Cell Disease [Internet]. ClinicalTrials.gov 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06144749"},{"key":"e_1_3_2_232_1","doi-asserted-by":"crossref","unstructured":"Gan G Ma T Zhang G et al. Luminescent probes for detecting and bioimaging of nitric oxide and carbon monoxide. TrAC Trends in Analytical Chemistry. 2023;168:117340. doi:10.1016\/j.trac.2023.117340","DOI":"10.1016\/j.trac.2023.117340"},{"key":"e_1_3_2_233_1","doi-asserted-by":"crossref","unstructured":"Zhang J An Q Li W et al. Rationally designed lipid droplets-selective two-photon nitric oxide probe for high-fidelity neuroinflammation evaluation. Sensors and Actuators B: Chemical. 2021;345:130329. doi:10.1016\/j.snb.2021.130329","DOI":"10.1016\/j.snb.2021.130329"},{"key":"e_1_3_2_234_1","doi-asserted-by":"crossref","unstructured":"Xu Q Zhang Y Zhu M et al. Bent-to-planar Si-rhodamines: a distinct rehybridization lights up NIR-II fluorescence for tracking nitric oxide in the Alzheimer's disease brain. Chem Sci. 2023;14:4091\u20134101. doi:10.1039\/d3sc00193h","DOI":"10.1039\/D3SC00193H"},{"key":"e_1_3_2_235_1","doi-asserted-by":"crossref","unstructured":"Morstein J Hofler D Ueno K et al. Ligand-Directed approach to activity-based sensing: developing palladacycle fluorescent probes that enable endogenous carbon monoxide detection. J Am Chem Soc. 2020;142:15917\u201315930. doi:10.1021\/jacs.0c06405","DOI":"10.1021\/jacs.0c06405"},{"key":"e_1_3_2_236_1","doi-asserted-by":"crossref","unstructured":"Quan FS Lee GJ. Analytical methods for detection of gasotransmitter hydrogen sulfide released from live cells. Biomed Res Int. 2021;2021:5473965. doi:10.1155\/2021\/5473965","DOI":"10.1155\/2021\/5473965"},{"key":"e_1_3_2_237_1","doi-asserted-by":"crossref","unstructured":"Jia TT Zhang Y Hou JT et al. H(2)S-based fluorescent imaging for pathophysiological processes. Front Chem. 2023;11:1126309. doi:10.3389\/fchem.2023.1126309","DOI":"10.3389\/fchem.2023.1126309"},{"key":"e_1_3_2_238_1","doi-asserted-by":"crossref","unstructured":"Feng W Xiao Q Wang L et al. A new fluorescent probe for hydrogen sulfide detection in solution and living cells. Molecules. 2023;28. doi:10.3390\/molecules28176195","DOI":"10.3390\/molecules28176195"},{"key":"e_1_3_2_239_1","doi-asserted-by":"crossref","unstructured":"Wang Y Zhang S Liu T et al. A red-emission fluorescent probe for intracellular biothiols and hydrogen sulfide imaging in living cells. Molecules. 2024;29. doi:10.3390\/molecules29071572","DOI":"10.3390\/molecules29071572"},{"key":"e_1_3_2_240_1","doi-asserted-by":"crossref","unstructured":"Hong S Gan Y Liu D et al. A novel NIR fluorescent probe for visualizing hydrogen sulfide in Alzheimer's disease. Analyst. 2024;149:4370\u20134377. doi:10.1039\/d4an00819g","DOI":"10.1039\/D4AN00819G"},{"key":"e_1_3_2_241_1","doi-asserted-by":"crossref","unstructured":"Marwah MK Manhoosh B Shokr H et al. Transdermal delivery of mitochondrial-targeted hydrogen sulphide donor AP39 protects against 6-hydroxydopamine-induced mitochondrial dysfunction. Eur J Pharm Biopharm. 2023;191:166\u2013174. doi:10.1016\/j.ejpb.2023.09.004","DOI":"10.1016\/j.ejpb.2023.09.004"},{"key":"e_1_3_2_242_1","doi-asserted-by":"crossref","unstructured":"Zhao Z Chen L Yang C et al. Nanomotor-based H(2)S donor with mitochondrial targeting function for treatment of Parkinson's disease. Bioact Mater. 2024;31:578\u2013589. doi:10.1016\/j.bioactmat.2023.09.001","DOI":"10.1016\/j.bioactmat.2023.09.001"},{"key":"e_1_3_2_243_1","doi-asserted-by":"crossref","unstructured":"Sestito S Daniele S Pietrobono D et al. Memantine prodrug as a new agent for Alzheimer's disease. Sci Rep. 2019;9:4612. doi:10.1038\/s41598-019-40925-8","DOI":"10.1038\/s41598-019-40925-8"},{"key":"e_1_3_2_244_1","doi-asserted-by":"crossref","unstructured":"Sestito S Pruccoli L Runfola M et al. Design and synthesis of H(2)S-donor hybrids: A new treatment for Alzheimer's disease? Eur J Med Chem. 2019;184:111745. doi:10.1016\/j.ejmech.2019.111745","DOI":"10.1016\/j.ejmech.2019.111745"},{"key":"e_1_3_2_245_1","doi-asserted-by":"crossref","unstructured":"Sarkar S Kumar R Matson JB. Hydrogels for gasotransmitter delivery: nitric oxide carbon monoxide and hydrogen sulfide. Macromol Biosci. 2024;24:e2300138. doi:10.1002\/mabi.202300138","DOI":"10.1002\/mabi.202300138"},{"key":"e_1_3_2_246_1","doi-asserted-by":"crossref","unstructured":"Liu Y Tan Y Cheng G et al. Customized intranasal hydrogel delivering methylene blue ameliorates cognitive dysfunction against Alzheimer's disease. Adv Mater. 2024;36:e2307081. doi:10.1002\/adma.202307081","DOI":"10.1002\/adma.202307081"},{"key":"e_1_3_2_247_1","doi-asserted-by":"crossref","unstructured":"Al Harthi S Alavi SE Radwan MA et al. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer's disease. Sci Rep. 2019;9:9563. doi:10.1038\/s41598-019-46032-y","DOI":"10.1038\/s41598-019-46032-y"},{"key":"e_1_3_2_248_1","doi-asserted-by":"crossref","unstructured":"Del Campo-Montoya R Luquin MR Puerta E et al. Hydrogels for brain repair: application to Parkinson's disease. Expert Opin Drug Deliv. 2022;19:1521\u20131537. doi:10.1080\/17425247.2022.2136161","DOI":"10.1080\/17425247.2022.2136161"},{"key":"e_1_3_2_249_1","doi-asserted-by":"crossref","unstructured":"Dubey H Ray A Dubey A et al. S-Nitrosoglutathione attenuates oxidative stress and improves retention memory dysfunctions in intra-cerebroventricular-streptozotocin rat model of sporadic Alzheimer's disease via activation of BDNF and nuclear factor erythroid 2-related factor-2 antioxidant signaling pathway. Neuropsychobiology. 2024;83:101\u2013113. doi:10.1159\/000538348","DOI":"10.1159\/000538348"},{"key":"e_1_3_2_250_1","doi-asserted-by":"crossref","unstructured":"Won JS Kim J Annamalai B et al. Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion. J Alzheimers Dis. 2013;34:621\u2013635. doi:10.3233\/JAD-121786","DOI":"10.3233\/JAD-121786"},{"key":"e_1_3_2_251_1","doi-asserted-by":"crossref","unstructured":"Annamalai B Won JS Choi S et al. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation. Biochem Biophys Res Commun. 2015;458:214\u2013219. doi:10.1016\/j.bbrc.2015.01.093","DOI":"10.1016\/j.bbrc.2015.01.093"},{"key":"e_1_3_2_252_1","doi-asserted-by":"crossref","unstructured":"Dubey H Dubey A Gulati K et al. S-nitrosoglutathione modulates HDAC2 and BDNF levels in the brain and improves cognitive deficits in experimental model of Alzheimer's disease in rats. Int J Neurosci. 2024;134:777\u2013785. doi:10.1080\/00207454.2022.2150190","DOI":"10.1080\/00207454.2022.2150190"},{"key":"e_1_3_2_253_1","doi-asserted-by":"crossref","unstructured":"Dubey H Gulati K Ray A. Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer's disease in rats. Neurotoxicology. 2018;66:58\u201365. doi:10.1016\/j.neuro.2018.03.001","DOI":"10.1016\/j.neuro.2018.03.001"},{"key":"e_1_3_2_254_1","doi-asserted-by":"crossref","unstructured":"Geravand S Karami M Sahraei H et al. Protective effects of L-arginine on Alzheimer's disease: modulating hippocampal nitric oxide levels and memory deficits in aluminum chloride-induced rat model. Eur J Pharmacol. 2023;958:176030. doi:10.1016\/j.ejphar.2023.176030","DOI":"10.1016\/j.ejphar.2023.176030"},{"key":"e_1_3_2_255_1","doi-asserted-by":"crossref","unstructured":"Karami M Geravand S Rahimpour M. Protective effect of L-arginine in an animal model of Alzheimer's disease induced by intra-hippocampal injection of AlCl3. Neurol India. 2022;70(l3):548\u2013553. doi:10.4103\/0028-3886.344672","DOI":"10.4103\/0028-3886.344672"},{"key":"e_1_3_2_256_1","doi-asserted-by":"crossref","unstructured":"Manukhina EB Pshennikova MG Goryacheva AV et al. Role of nitric oxide in prevention of cognitive disorders in neurodegenerative brain injuries in rats. Bull Exp Biol Med. 2008;146:391\u2013395. doi:10.1007\/s10517-009-0315-7","DOI":"10.1007\/s10517-009-0315-7"},{"key":"e_1_3_2_257_1","doi-asserted-by":"crossref","unstructured":"Bortolanza M Bariotto-Dos-Santos KD Dos-Santos-Pereira M et al. Antidyskinetic effect of 7-nitroindazole and sodium nitroprusside associated with amantadine in a rat model of Parkinson's disease. Neurotox Res. 2016;30:88\u2013100. doi:10.1007\/s12640-016-9618-4","DOI":"10.1007\/s12640-016-9618-4"},{"key":"e_1_3_2_258_1","doi-asserted-by":"crossref","unstructured":"Ribeiro DL Guimaraes RP Bariotto-Dos-Santos K et al. Sodium nitroprusside enhances stepping test performance and increases medium spiny neurons responsiveness to cortical inputs in a rat model of levodopa-induced dyskinesias. Eur J Neurosci. 2024;59:1604\u20131620. doi:10.1111\/ejn.16259","DOI":"10.1111\/ejn.16259"},{"key":"e_1_3_2_259_1","doi-asserted-by":"crossref","unstructured":"Kim HJ Joe Y Chen Y et al. Carbon monoxide attenuates amyloidogenesis via down-regulation of NF-kappaB-mediated BACE1 gene expression. Aging Cell. 2019;18:e12864. doi:10.1111\/acel.12864","DOI":"10.1111\/acel.12864"},{"key":"e_1_3_2_260_1","doi-asserted-by":"crossref","unstructured":"Rose KN Zorlu M Fassini A et al. Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk of Parkinson's among smokers. NPJ Parkinsons Dis. 2024;10:152. doi:10.1038\/s41531-024-00763-6","DOI":"10.1038\/s41531-024-00763-6"},{"key":"e_1_3_2_261_1","doi-asserted-by":"crossref","unstructured":"Xu X Song N Wang R et al. Preferential heme oxygenase-1 activation in striatal astrocytes antagonizes dopaminergic neuron degeneration in MPTP-intoxicated mice. Mol Neurobiol. 2016;53:5056\u20135065. doi:10.1007\/s12035-015-9437-2","DOI":"10.1007\/s12035-015-9437-2"},{"key":"e_1_3_2_262_1","doi-asserted-by":"crossref","unstructured":"Aboulhoda BE Rashed LA Ahmed H et al. Hydrogen sulfide and mesenchymal stem cells-extracted microvesicles attenuate LPS-induced Alzheimer's disease. J Cell Physiol. 2021;236:5994\u20136010. doi:10.1002\/jcp.30283","DOI":"10.1002\/jcp.30283"},{"key":"e_1_3_2_263_1","doi-asserted-by":"crossref","unstructured":"Liu H Deng Y Gao J et al. Sodium hydrosulfide attenuates beta-amyloid-induced cognitive deficits and neuroinflammation via modulation of MAPK\/NF-kappaB pathway in rats. Curr Alzheimer Res. 2015;12:673\u2013683. doi:10.2174\/1567205012666150713102326","DOI":"10.2174\/1567205012666150713102326"},{"key":"e_1_3_2_264_1","doi-asserted-by":"crossref","unstructured":"Fan H Guo Y Liang X et al. Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model. J Biomed Res. 2013;27:296\u2013304. doi:10.7555\/JBR.27.20120100","DOI":"10.7555\/JBR.27.20120100"},{"key":"e_1_3_2_265_1","doi-asserted-by":"crossref","unstructured":"Xuan A Long D Li J et al. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. J Neuroinflammation. 2012;9:202. doi:10.1186\/1742-2094-9-202","DOI":"10.1186\/1742-2094-9-202"},{"key":"e_1_3_2_266_1","doi-asserted-by":"crossref","unstructured":"He XL Yan N Zhang H et al. Hydrogen sulfide improves spatial memory impairment and decreases production of abeta in APP\/PS1 transgenic mice. Neurochem Int. 2014;67:1\u20138. doi:10.1016\/j.neuint.2014.01.004","DOI":"10.1016\/j.neuint.2014.01.004"},{"key":"e_1_3_2_267_1","doi-asserted-by":"crossref","unstructured":"Vandini E Ottani A Zaffe D et al. Mechanisms of hydrogen sulfide against the progression of severe Alzheimer's disease in transgenic mice at different ages. Disease in Transgenic Mice at Different Ages. 2019;103:50\u201360. doi:10.1159\/000494113","DOI":"10.1159\/000494113"},{"key":"e_1_3_2_268_1","doi-asserted-by":"crossref","unstructured":"Giuliani D Ottani A Zaffe D et al. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. Neurobiol Learn Mem. 2013;104:82\u201391. doi:10.1016\/j.nlm.2013.05.006","DOI":"10.1016\/j.nlm.2013.05.006"},{"key":"e_1_3_2_269_1","doi-asserted-by":"crossref","unstructured":"Zhao FL Fang F Qiao PF et al. AP39 a mitochondria-targeted hydrogen sulfide donor supports cellular bioenergetics and protects against Alzheimer's disease by preserving mitochondrial function in APP\/PS1 mice and neurons. Oxid Med Cell Longev. 2016;2016:8360738. doi:10.1155\/2016\/8360738","DOI":"10.1155\/2016\/8360738"},{"key":"e_1_3_2_270_1","doi-asserted-by":"crossref","unstructured":"Giovinazzo D Bursac B Sbodio JI et al. Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3beta and inhibiting Tau hyperphosphorylation. Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). doi:10.1073\/pnas.2017225118","DOI":"10.1073\/pnas.2017225118"},{"key":"e_1_3_2_271_1","doi-asserted-by":"crossref","unstructured":"Cheng XJ Gu JX Pang YP et al. Tacrine-Hydrogen sulfide donor hybrid ameliorates cognitive impairment in the aluminum chloride mouse model of Alzheimer's disease. ACS Chem Neurosci. 2019;10:3500\u20133509. doi:10.1021\/acschemneuro.9b00120","DOI":"10.1021\/acschemneuro.9b00120"},{"key":"e_1_3_2_272_1","doi-asserted-by":"crossref","unstructured":"Mostafa DK El Azhary NM Nasra RA. The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment neuroinflammation and oxidative stress in rats: involvement of asymmetric dimethylarginine. Can J Physiol Pharmacol. 2016;94:699\u2013708. doi:10.1139\/cjpp-2015-0316","DOI":"10.1139\/cjpp-2015-0316"},{"key":"e_1_3_2_273_1","doi-asserted-by":"crossref","unstructured":"Salehpour M Ashabi G Kashef M et al. Aerobic training with naringin supplementation improved spatial cognition via H(2)S signaling pathway in Alzheimer's disease model rats. Exp Aging Res. 2023;49:407\u2013420. doi:10.1080\/0361073X.2022.2101303","DOI":"10.1080\/0361073X.2022.2101303"},{"key":"e_1_3_2_274_1","doi-asserted-by":"crossref","unstructured":"Rao SP Xie W Christopher Kwon YI et al. Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer's disease pathology and oxidative stress in vivo. Redox Biol. 2022;57:102484. doi:10.1016\/j.redox.2022.102484","DOI":"10.1016\/j.redox.2022.102484"},{"key":"e_1_3_2_275_1","doi-asserted-by":"crossref","unstructured":"Xi Y Zhang Y Zhou Y et al. Effects of methionine intake on cognitive function in mild cognitive impairment patients and APP\/PS1 Alzheimer's disease model mice: role of the cystathionine-beta-synthase\/H(2)S pathway. Redox Biol. 2023;59:102595. doi:10.1016\/j.redox.2022.102595","DOI":"10.1016\/j.redox.2022.102595"},{"key":"e_1_3_2_276_1","doi-asserted-by":"crossref","unstructured":"Liu F Tian Q Tang HL et al. Hydrogen sulfide attenuates depression-like behaviours in Parkinson's disease model rats by improving synaptic plasticity in a hippocampal warburg effect-dependent manner. Pharmacol Biochem Behav. 2024;234:173677. doi:10.1016\/j.pbb.2023.173677","DOI":"10.1016\/j.pbb.2023.173677"},{"key":"e_1_3_2_277_1","doi-asserted-by":"crossref","unstructured":"Tian Q Tang HL Tang YY et al. Hydrogen sulfide attenuates the cognitive dysfunction in Parkinson's disease rats via promoting hippocampal microglia M2 polarization by enhancement of hippocampal warburg effect. Oxid Med Cell Longev. 2022;2022:2792348. doi:10.1155\/2022\/2792348","DOI":"10.1155\/2022\/2792348"},{"key":"e_1_3_2_278_1","doi-asserted-by":"crossref","unstructured":"Jiang W Zou W Hu M et al. Hydrogen sulphide attenuates neuronal apoptosis of substantia nigra by re-establishing autophagic flux via promoting leptin signalling in a 6-hydroxydopamine rat model of Parkinson's disease. Clin Exp Pharmacol Physiol. 2022;49:122\u2013133. doi:10.1111\/1440-1681.13587","DOI":"10.1111\/1440-1681.13587"},{"key":"e_1_3_2_279_1","doi-asserted-by":"crossref","unstructured":"Yang SQ Tian Q Li D et al. Leptin mediates protection of hydrogen sulfide against 6-hydroxydopamine-induced Parkinson's disease: involving enhancement in warburg effect. Neurochem Int. 2020;135:104692. doi:10.1016\/j.neuint.2020.104692","DOI":"10.1016\/j.neuint.2020.104692"},{"key":"e_1_3_2_280_1","doi-asserted-by":"crossref","unstructured":"Hu LF Lu M Tiong CX et al. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell. 2010;9:135\u2013146. doi:10.1111\/j.1474-9726.2009.00543.x","DOI":"10.1111\/j.1474-9726.2009.00543.x"},{"key":"e_1_3_2_281_1","doi-asserted-by":"crossref","unstructured":"Wang M Zhu J Pan Y et al. Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson's disease. J Neurosci Res. 2015;93:487\u2013494. doi:10.1002\/jnr.23504","DOI":"10.1002\/jnr.23504"},{"key":"e_1_3_2_282_1","doi-asserted-by":"crossref","unstructured":"Lu M Zhao FF Tang JJ et al. The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels. Antioxid Redox Signal. 2012;17:849\u2013859. doi:10.1089\/ars.2011.4507.","DOI":"10.1089\/ars.2011.4507"},{"key":"e_1_3_2_283_1","doi-asserted-by":"crossref","unstructured":"Sarookhani MR Haghdoost-Yazdi H Sarbazi-Golezari A et al. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease. Behav Pharmacol. 2018;29:336\u2013343. doi:10.1097\/FBP.0000000000000358","DOI":"10.1097\/FBP.0000000000000358"},{"key":"e_1_3_2_284_1","doi-asserted-by":"crossref","unstructured":"Hou X Yuan Y Sheng Y et al. GYY4137 an H(2)S slow-releasing donor prevents nitrative stress and alpha-synuclein nitration in an MPTP mouse model of Parkinson's disease. Front Pharmacol. 2017;8:741. doi:10.3389\/fphar.2017.00741","DOI":"10.3389\/fphar.2017.00741"},{"key":"e_1_3_2_285_1","doi-asserted-by":"crossref","unstructured":"Kida K Yamada M Tokuda K et al. Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal. 2011;15:343\u2013352. doi:10.1089\/ars.2010.3671","DOI":"10.1089\/ars.2010.3671"},{"key":"e_1_3_2_286_1","doi-asserted-by":"crossref","unstructured":"Yang YJ Zhao Y Yu B et al. GluN2B-containing NMDA receptors contribute to the beneficial effects of hydrogen sulfide on cognitive and synaptic plasticity deficits in APP\/PS1 transgenic mice. Neuroscience. 2016;335:170\u2013183. doi:10.1016\/j.neuroscience.2016.08.033","DOI":"10.1016\/j.neuroscience.2016.08.033"},{"key":"e_1_3_2_287_1","doi-asserted-by":"crossref","unstructured":"Liu Y Deng Y Liu H et al. Hydrogen sulfide ameliorates learning memory impairment in APP\/PS1 transgenic mice: A novel mechanism mediated by the activation of Nrf2. Pharmacol Biochem Behav. 2016;150-151:207\u2013216. doi:10.1016\/j.pbb.2016.11.002","DOI":"10.1016\/j.pbb.2016.11.002"},{"key":"e_1_3_2_288_1","doi-asserted-by":"crossref","unstructured":"He XL Yan N Chen XS et al. Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K\/Akt pathway in the brain of APP\/PS1 transgenic mouse. Pharmacol Rep. 2016;68:975\u2013982. doi:10.1016\/j.pharep.2016.05.006","DOI":"10.1016\/j.pharep.2016.05.006"},{"key":"e_1_3_2_289_1","doi-asserted-by":"crossref","unstructured":"Huang HJ Chen SL Hsieh-Li HM. Administration of NaHS attenuates footshock-induced pathologies and emotional and cognitive dysfunction in triple transgenic Alzheimer's mice. Front Behav Neurosci. 2015;9:312. doi:10.3389\/fnbeh.2015.00312","DOI":"10.3389\/fnbeh.2015.00312"},{"key":"e_1_3_2_290_1","doi-asserted-by":"crossref","unstructured":"Hacioglu G Cirrik S Tezcan Yavuz B et al. The BDNF-TrkB signaling pathway is partially involved in the neuroprotective effects of hydrogen sulfide in Parkinson's disease. Eur J Pharmacol. 2023;944:175595. doi:10.1016\/j.ejphar.2023.175595","DOI":"10.1016\/j.ejphar.2023.175595"},{"key":"e_1_3_2_291_1","doi-asserted-by":"crossref","unstructured":"Minaei A Sarookhani MR Haghdoost-Yazdi H et al. Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress. Toxicol Appl Pharmacol. 2021;423:115558. doi:10.1016\/j.taap.2021.115558","DOI":"10.1016\/j.taap.2021.115558"},{"key":"e_1_3_2_292_1","doi-asserted-by":"crossref","unstructured":"Sarukhani M Haghdoost-Yazdi H Sarbazi Golezari A et al. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral histological and biochemical studies. Neurol Res. 2018;40:523\u2013531. doi:10.1080\/01616412.2017.1390903","DOI":"10.1080\/01616412.2017.1390903"},{"key":"e_1_3_2_293_1","doi-asserted-by":"crossref","unstructured":"Yuan YQ Wang YL Yuan BS et al. Impaired CBS-H(2)S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson's disease. Brain Behav Immun. 2018;67:77\u201390. doi:10.1016\/j.bbi.2017.07.159","DOI":"10.1016\/j.bbi.2017.07.159"},{"key":"e_1_3_2_294_1","doi-asserted-by":"crossref","unstructured":"Yin WL Yin WG Huang BS et al. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced Parkinson's disease rats. Neurosci Lett. 2017;657:45\u201352. doi:10.1016\/j.neulet.2017.07.019","DOI":"10.1016\/j.neulet.2017.07.019"},{"key":"e_1_3_2_295_1","doi-asserted-by":"crossref","unstructured":"Liu Y Liao S Quan H et al. Involvement of microRNA-135a-5p in the protective effects of hydrogen sulfide against Parkinson's disease. Cell Physiol Biochem. 2016;40:18\u201326. doi:10.1159\/000452521","DOI":"10.1159\/000452521"},{"key":"e_1_3_2_296_1","doi-asserted-by":"crossref","unstructured":"Xie L Hu LF Teo XQ et al. Therapeutic effect of hydrogen sulfide-releasing L-dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model. PLoS One. 2013;8:e60200. doi:10.1371\/journal.pone.0060200","DOI":"10.1371\/journal.pone.0060200"}],"container-title":["Redox Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13510002.2025.2592413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:57:14Z","timestamp":1765817834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13510002.2025.2592413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":295,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13510002.2025.2592413"],"URL":"https:\/\/doi.org\/10.1080\/13510002.2025.2592413","relation":{},"ISSN":["1351-0002","1743-2928"],"issn-type":[{"value":"1351-0002","type":"print"},{"value":"1743-2928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yrer20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yrer20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2592413"}}